NCT01464151View on ClinicalTrials.gov

Risk Factors for Colorectal Cancer in Patients With Inflammatory Bowel Disease Undergoing Surveillance: a Prospective Cohort Study

CompletedOBSERVATIONAL

Enrollment

613

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions

Inflammatory Bowel DiseaseColorectal Cancer

Trial Locations (4)

Unknown

AMC, Amsterdam

Radboud UMC, Nijmegen

2333 ZA

LUMC, Leiden

3584 CX

UMC Utrecht, Utrecht

Sponsors

Collaborators (1)

Ferring Pharmaceuticals

All Listed Sponsors

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Ferring Pharmaceuticals

INDUSTRY

lead

UMC Utrecht

OTHER